Neurovalens
Developer of non-invasive neurostimulation products designed to treat global health epidemics. The company's medical device technology offers transdermal activation of the homeostatic nuclei of the br...
Valuation
$0
Share Price
N/A
Total Raised
$28M
Last Round
N/A